US approves HIV home test kit


An HIV home test kit has been approved for marketing in the US. The ‘OraQuick’ kit from US diagnostics firm OraSure, is already in use by clinics, but until now the company has not been allowed to market it for home use.

Users collect an oral sample by swabbing their gums and putting the swab into a buffer solution. The kit then provides a result in 20–40 minutes.

The Food and Drug Administration says that the test should not be considered conclusive. It gets the answer right 92% of the time when the user is infected and 99.98% when they aren't. Despite this shortcoming, the FDA adds: ‘The test has the potential to identify large numbers of previously undiagnosed HIV infections, especially if used by those unlikely to use standard screening methods.’

OraSure is planning to launch the home test version of the kit in October.


Related Content

Pharma goes hi-tech

5 June 2015 Premium contentFeature

news image

Technology and telecommunications have the potential to revolutionise healthcare, as Anthony King reports

US opens up home DNA screening

25 February 2015 Business

news image

FDA approves single disease genetic test and clears pathway for similar devices

Most Commented

Electric choc treatment promises lower fat chocolate

22 June 2016 Research

news image

Problem of reduced fat chocolate gumming up factories’ pipelines overcome

Behind closed doors: How to win the Nobel prize

7 October 2015 Comments

news image

Bengt Norden addresses the myths and rumours surrounding the world's most prestigious science prize